Paul Hartmann AG
F:PHH2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Paul Hartmann AG
F:PHH2
|
DE |
|
D
|
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
|
ID |
Multiples-Based Value
The Multiples-Based Value of one
PHH2
stock under the Base Case scenario is
447.04
EUR.
Compared to the current market price of 212 EUR,
Paul Hartmann AG
is
Undervalued by 53%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PHH2 Competitors Multiples
Paul Hartmann AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Paul Hartmann AG
F:PHH2
|
749.4m EUR | 0.3 | 9.3 | 9.1 | 9.1 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.2T JPY | 10.1 | 36.8 | 26.6 | 32 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
54.3B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.2B CHF | 3.6 | 38.2 | 14.7 | 28.6 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
98.2B DKK | 3.5 | 24.5 | 12.9 | 15.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.9B USD | 2.9 | 28.9 | 12.4 | 17 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.4B GBP | 2.4 | 33.4 | 11.7 | 18.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 1.1 | -15.1 | 16.6 | 53.6 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
890.2B JPY | 6.9 | 50.3 | 23.8 | 32.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
38.2B CNY | 8.4 | 23.1 | 20.8 | 20.8 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
35.8B CNY | 3.6 | 21 | 31 | 31 |